跳至主要内容
临床试验/NCT00181246
NCT00181246已完成不适用

Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain

Johns Hopkins University0 个研究点目标入组 53 人开始时间: 2003年10月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
53
主要终点
Change in pain intensity (0-10) and daily activity

研究概览

简要总结

The efficacy of fentanyl TTS for the treatment of neuropathic pain remains to be established, although opioids in general are clearly effective for neuropathic pain and fentanyl TTS has been shown to be effective for treating other types of pain. We propose to measure functional outcomes, pain relief and side effects of fentanyl TTS for the treatment of neuropathic pain. Measures will be made at baseline and after titrating the drug to an effective level.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Neuropathic pain persisting for > 3 months
  • Pain over the immediate previous three months
  • The average of the least and usual pain intensity rating of 3 or greater (0-10 numerical rating scale) during the last week prior to enrollment

排除标准

  • A history of substance abuse
  • Allergic reaction to an opioid
  • Significant pain of alternate etiology other than the neuropathic pain state
  • Severe pulmonary disease
  • Recent myocardial infarction (within the preceding three months)
  • Pregnancy
  • Encephalopathy
  • Those with life expectancy of less than six months and HIV seropositivity.

结局指标

主要结局

Change in pain intensity (0-10) and daily activity

次要结局

  • Cognition (digital symbol and grooved peg-board)
  • Impairment of function (MPI) and affect (BDI)
  • Pain relief (0-100%)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Efficacy of Transdermal Fentanyl for Chronic... | 临床试验